Clinical Trial Update: Study Evaluating DVS-233 SR in Elderly Outpatients With Major Depressive Disorder [NA]

View source ↗

Summary

A completed clinical trial evaluated DVS-233 SR for major depressive disorder in elderly outpatients; sponsor Wyeth is now part of Pfizer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• DVS-233 SR

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Major Depressive Disorder | NA | Status: COMPLETED